Evidence map›Paper›PMID 40317435›Full record

ArticleMolecular diversity2026

Unleashing the potential of traditional Chinese medicine: a computational approach to discovering drug targets utilizing the CSLN and molecular dynamics.

Qi Geng, Pengcheng Zhao, Zhiwen Cao, Zhenyi Wu, Changqi Shi, Lulu Zhang, Lan Yan, Xiaomeng Zhang, Peipei Lu, Jianyu Shi and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Qi GengInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, People's Republic of China.
Pengcheng ZhaoSchool of Life Science, Northwestern Polytechnical University, Xi'an, 710072, China.
Zhiwen CaoInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, People's Republic of China.
Zhenyi WuSchool of Life Science, Northwestern Polytechnical University, Xi'an, 710072, China.
Changqi ShiInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, People's Republic of China.
Lulu ZhangInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, People's Republic of China.
Lan YanInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, People's Republic of China.
Xiaomeng ZhangInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, People's Republic of China.
Peipei LuInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, People's Republic of China.
Jianyu ShiSchool of Life Science, Northwestern Polytechnical University, Xi'an, 710072, China. jianyushi@nwpu.edu.cn.
Cheng LuInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, People's Republic of China. lv_cheng0816@163.com.

Funding

The National Natural Science Foundation of China 82074269This research was funded by Scientific and technological innovation project of China Academy of Chinese Medical Sciences CI2023C065YLL
6 · The paper itself

Abstract

The diverse chemical components of traditional Chinese medicine (TCM) exhibit significant therapeutic potential; however, the action mechanisms of these compounds often remain unclear. The use of drug-target prediction can aid in identifying the specific targets of TCM, thereby revealing their bioactivity and mechanisms. The efficiency, cost-effectiveness, and powerful predictive capabilities of artificial intelligence algorithms have led to their emergence as effective tools for accelerating drug-target interaction analysis. To systematically investigate TCM interaction mechanisms, we integrated cosine‑correlation and similarity‑comparison of local network (CSLN) and molecular dynamics (MD) simulations. The CSLN algorithm predicts that 11-beta-hydroxysteroid dehydrogenase-1 (HSD11B1) serves as a common target for the synergistic effects of triptolide (TP) and glycyrrhizic acid (GA). MD simulations indicate that both TP and GA can maintain stable interactions with HSD11B1 and form a common binding hot region. Surface plasmon resonance (SPR) experiments reveal that both TP and GA can effectively bind to HSD11B1, with binding constants of 29.21 μM and 31.75 μM, respectively. When used in combination, the binding constant is 5.74 μM. The combination of CSLN and MD simulations represents an effective tool for the initial analysis and simulation of interaction patterns between TCM and their targets at the computational level. These findings enhance our understanding of the interaction mechanisms between drugs.

Indexed as

Drug DiscoveryDrugs, Chinese HerbalMedicine, Chinese TraditionalMolecular Dynamics Simulation11-beta-Hydroxysteroid Dehydrogenase Type 1AlgorithmsDiterpenesEpoxy CompoundsGlycyrrhizic AcidHumansMolecular Docking SimulationPhenanthrenesProtein BindingTriterpenes11-beta-Hydroxysteroid Dehydrogenase Type 1DiterpenesDrugs, Chinese HerbalEpoxy CompoundsGlycyrrhizic AcidPhenanthrenestriptolideTriterpenesArtificial intelligenceGlycyrrhizic acidMolecular dynamicsTraditional Chinese medicineTriptolide

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.